Optimising patient outcomes in non-valvular atrial fibrillation (NVAF): Peri-procedural use of non-vitamin K antagonist oral anticoagulants (NOACs) in cardiac interventions.

28 August 2021 (13:15 - 14:15)
Organised by:

ESC 365 is supported by

ESC 365 is supported by